Macrogenics (MGNX) Operating Margin Growth (1y) (2013 - 2026)
Macrogenics (MGNX) Operating Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | 16,215.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,215.00 |
| Dec 31, 2025 | 10,275.00 |
| Sep 30, 2025 | -2,336.00 |
| Jun 30, 2025 | 37,359.00 |
| Mar 31, 2025 | 26,729.00 |
| Dec 31, 2024 | 32,830.00 |
| Sep 30, 2024 | 39,041.00 |
| Jun 30, 2024 | -19,658.00 |
| Mar 31, 2024 | -43,353.00 |
| Dec 31, 2023 | -47,678.00 |
| Sep 30, 2023 | -28,167.00 |
| Jun 30, 2023 | -18,152.00 |
| Mar 31, 2023 | 44,342.00 |
| Dec 31, 2022 | 42,804.00 |
| Sep 30, 2022 | 27,852.00 |
| Jun 30, 2022 | -2,980.00 |
| Mar 31, 2022 | -29,644.00 |
| Dec 31, 2021 | -40,080.00 |
| Sep 30, 2021 | -14,035.00 |
| Jun 30, 2021 | 10,259.00 |